XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.3

Stockholders’ Equity (Tables)

9 Months Ended

Sep. 30, 2024

Equity [Abstract]

Summary of RSU Activity

For the nine months ended September 30, 2024, a summary of RSU activity is as follows:

 Summary of RSU Activity

		Shares				Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2023			152,703			$	18.03
Granted			399,073				0.33
Cancelled			(2,140	)			10.09
Vested and released			(34,361	)			15.06
Outstanding as of September 30, 2024			515,275				4.66
Vested as of September 30, 2024			149,046				14.87
Unvested as of September 30, 2024			366,229			$	0.51

 

For the nine months ended September 30, 2023, a summary of RSU activity is as follows:

		Shares				Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2022			51,484			$	46.20
Granted			100,036				7.11
Cancelled			(7,677	)			31.46
Vested and released			(19,375	)			7.68
Outstanding as of September 30, 2023			124,468				21.70
Vested as of September 30, 2023			103,511				20.28
Unvested as of September 30, 2023			20,957			$	28.70

 

Schedule of Options Activity

For the nine months ended September 30, 2024, a summary of the options activity is as follows:

 Schedule of Options Activity

		Shares				Weighted Average Exercise Price				Weighted Average Fair Value				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Outstanding as of December 31, 2023			125,264			$	40.61			$	22.04				23.80			$	45,880
Granted			—				—				—				—				—
Exercised			—				—				—				—				—
Expired/Forfeited			(122,514	)			39.11				21.24				—				—
Outstanding as of September 30, 2024			2,750			$	105.96			$	57.01				1.78			$	—
Exercisable as of September 30, 2024			2,750			$	105.96			$	57.01				1.78			$	—

 

For the nine months ended September 30, 2023, a summary of the options activity is as follows:

		Shares				Weighted Average Exercise Price				Weighted Average Fair Value				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Outstanding as of December 31, 2022			128,059			$	43.68			$	23.76				3.33			$	9,750
Granted			16,250				6.45				2.96				3.02				—
Exercised			—				—				—				—				—
Expired/Forfeited			(7,230	)			69.20				38.12				—				—
Outstanding as of September 30, 2023			137,079			$	37.92			$	20.54				2.84			$	6,194
Exercisable as of September 30, 2023			114,746			$	43.56			$	23.70				2.53			$	6,194

 

Schedule of Significant Weighted Average Assumptions

For the nine months ended September 30, 2024 and 2023, the significant assumptions relating to the valuation of the Company’s stock options granted were as follows:

 Schedule of Significant Weighted Average Assumptions

		2024				2023
		September 30,
		2024				2023
Stock price		$	—			$	6.40
Dividend yield			—	%			—	%
Expected life (years)			—				3.02
Expected volatility			—	%			63.64	%
Risk-free interest rate			—	%			4.22	%

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration